Simpson, E. L. ., Silverberg, J., Nosbaum, A., Winthrop, K., Guttman-Yassky, E., Hoffmeister, K. M., Egeberg, A., Valdez, H., Fan, H., Farooqui, S. A., Chan, G. L., Alderfer, J., Romero, W., & Johnson, S. (2023). Safety of Abrocitinib in 3582 Patients With Moderate-to-Severe Atopic Dermatitis With Over 900 Patients Exposed for Almost 2 Years. SKIN The Journal of Cutaneous Medicine, 7(2), s150. https://doi.org/10.25251/skin.7.supp.150